tiprankstipranks

Top Coronavirus Therapeutics Stocks

Compare coronavirus therapeutics stocks. These companies are making significant advances in COVID-19 diagnostics and treatment. Get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Analyst Price Target
Market Cap
Yearly Gain
Analyst Consensus
Smart Score
Follow
Gilead Sciences
$65.34
▲ $0.16 (0.25%)
$72.00
(10.19% Upside)
$81.90B-5.63%
4Buy
9Hold
0Sell
Moderate Buy
premium
Sorrento Therapeutics
$1.86
▼ $0.19 (9.27%)
$5.00
(168.82% Upside)
$723.44M-79.17%
1Buy
0Hold
0Sell
Moderate Buy
premium
Amgen
$250.86
▲ $1.16 (0.46%)
$242.69
(-3.26% Downside)
$134.19B15.95%
4Buy
8Hold
2Sell
Hold
premium
AbbVie
$141.85
▲ $0.56 (0.4%)
$159.38
(12.36% Upside)
$250.80B24.28%
7Buy
5Hold
1Sell
Moderate Buy
premium
GlaxoSmithKline
$34.06
▼ $0.19 (0.55%)
$68.17B-16.40%
0Buy
0Hold
1Sell
Moderate Sell
premium
Eli Lilly & Co
$322.77
▲ $6.05 (1.91%)
$354.90
(9.95% Upside)
$306.69B20.82%
10Buy
0Hold
0Sell
Strong Buy
premium
Regeneron
$618.36
▼ $6.47 (1.04%)
$669.69
(8.30% Upside)
$67.41B-6.77%
7Buy
8Hold
1Sell
Moderate Buy
premium

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Coronavirus Therapeutics Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Coronavirus Therapeutics Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
Sorrento Therapeutics Inc
premium
premium
Buy
premium
premium
Reiterated
Gilead Sciences
premium
premium
Hold
premium
premium
Reiterated
Amgen Inc
premium
premium
Buy
premium
premium
Reiterated
Regeneron Pharmaceuticals
premium
premium
Sell
premium
premium
Reiterated
Eli Lilly And Company
premium
premium
Buy
premium
premium
Reiterated
Abbvie
premium
premium
Hold
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Sell
premium
premium
Downgraded
Gilead Sciences
premium
premium
Buy
premium
premium
Reiterated
Gilead Sciences
premium
premium
Hold
premium
premium
Reiterated
Amgen Inc
premium
premium
Hold
premium
premium
Reiterated

Most Recent Earnings of Coronavirus Therapeutics Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Gilead Sciences
Aug 02, 2022
2022 (Q2)
1.52 / 1.58
1.87
-15.51% (-0.29)
Sorrento Therapeutics
Aug 11, 2022
2022 (Q2)
-0.54 / -0.54
-0.365
-48.77% (-0.18)
Amgen
Aug 04, 2022
2022 (Q2)
4.43 / 4.65
4.38
6.16% (+0.27)
AbbVie
Jul 29, 2022
2022 (Q2)
3.32 / 3.37
3.11
8.36% (+0.26)
GlaxoSmithKline
Jul 27, 2022
2022 (Q2)
0.64 / 0.83
0.787
6.10% (+0.05)
Eli Lilly & Co
Aug 04, 2022
2022 (Q2)
1.70 / 1.25
1.87
-33.16% (-0.62)
Regeneron
Aug 03, 2022
2022 (Q2)
8.62 / 9.77
25.8
-62.13% (-16.03)

Coronavirus Therapeutics Stocks - FAQ

Which Coronavirus Therapeutics stocks have a "Strong Buy" analyst rating?
These Coronavirus Therapeutics stocks currently have a "Strong Buy" analyst rating consensus:
Eli Lilly & Co - Strong Buy, based on 10 analyst ratings, 10 Buy, 0 Hold, and 0 Sell.
    Are Coronavirus Therapeutics stocks overpriced?
    Gilead Sciences's stock price is currently $65.34, and its average 12-month price target is $72.00.
      Sorrento Therapeutics's stock price is currently $1.86, and its average 12-month price target is $5.00.
        Amgen's stock price is currently $250.86, and its average 12-month price target is $242.69.
          AbbVie's stock price is currently $141.85, and its average 12-month price target is $159.38.
            GlaxoSmithKline's stock price is currently $34.06, and its average 12-month price target is N/A.
              Eli Lilly & Co's stock price is currently $322.77, and its average 12-month price target is $354.90.
                Regeneron's stock price is currently $618.36, and its average 12-month price target is $669.69.
                  Which Coronavirus Therapeutics stocks pay dividends?
                  Gilead Sciences currently pays a dividend of $0.73 which represents an annual dividend yield of 4.42%. Gilead Sciences's next Ex-dividend date is September 14, 2022 and its next payout date is September 29, 2022.
                    Sorrento Therapeutics does not currently pay dividends.
                      Amgen does not currently pay dividends.
                        AbbVie does not currently pay dividends.
                          GlaxoSmithKline does not currently pay dividends.
                            Eli Lilly & Co does not currently pay dividends.
                              Regeneron does not currently pay dividends.

                                Latest News​


                                Coronavirus Therapeutics Stock Events

                                Stock
                                Type
                                Date
                                Gilead Sciences
                                Ex-Dividend Date
                                Sep 14, 2022
                                Gilead Sciences
                                Earnings Release
                                Oct 27, 2022
                                Amgen
                                Earnings Release
                                Nov 01, 2022
                                Eli Lilly & Co
                                Earnings Release
                                Nov 01, 2022
                                GlaxoSmithKline
                                Earnings Release
                                Nov 02, 2022

                                Popular Stocks

                                Company
                                Price & Change
                                Follow
                                Alibaba
                                Apple
                                Amazon
                                Tesla
                                Nio